Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 19, 2018European Journal of Nuclear Medicine and Molecular ImagingOpen Access

Defining the optimal method for measuring baseline metabolic tumour volume in diffuse large B cell lymphoma

View Full Paper
Ask AI
Bookmark
Share

Authors

HIHajira IlyasNMN. George MikhaeelJDJoel Dunn

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Ilyas et al. (2018) studied this question.

synapsesocial.com/papers/6a014eec413f0c047f2d8ab0https://doi.org/10.1007/s00259-018-3953-z
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Role of Imaging in the Staging and Response Assessment of Lymphoma: Consensus of the International Conference on Malignant Lymphomas Imaging Working Group2014 · 1,677 citations
  2. 2Combination of baseline metabolic tumour volume and early response on PET/CT improves progression-free survival prediction in DLBCL2016 · 308 citations
  3. 3Assessment of tumour size in PET/CT lung cancer studies: PET- and CT-based methods compared to pathology2012 · 73 citations
  4. 4Total lesion glycolysis in positron emission tomography is a better predictor of outcome than the International Prognostic Index for patients with diffuse large B cell lymphoma2012 · 157 citations